Matthew Donahue

Dr. Matthew Donahue

Chemistry and Biochemistry, University of Southern Mississippi, Hattiesburg, Mississippi, USA
orcid
The dude abides...

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 January 2008 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
KHKi Bum Hong
Ki Bum Hong
MDMatthew Donahue
Matthew Donahue
JJJeffrey N. Johnston
Jeffrey N. Johnston

14 September 2018 in ACS Medicinal Chemistry Letters
Verified
Journal Article
Closed access
NJNicholas G. Jentsch
Nicholas G. Jentsch
AHAlison P. Hart
Alison P. Hart
JHJared D. Hume
Jared D. Hume
JSJian Sun
Jian Sun
KMKaitlin A. McNeely
Kaitlin A. McNeely
JKJACQUES KESSL
JACQUES KESSL

28 September 2018 in Beilstein Journal of Organic Chemistry
Verified
Journal Article
Open access
PDF file
NJNicholas G. Jentsch
Nicholas G. Jentsch
JHJared D. Hume
Jared D. Hume
ECEmily B. Crull
Emily B. Crull
SBSamer M. Beauti
Samer M. Beauti
APAmy H. Pham
Amy H. Pham
MDMatthew Donahue
Matthew Donahue
A convenient two-step synthesis of ethyl 4-hydroxy-2-methylquinoline-3-carboxylate derivatives has been developed starting from commercially available 2-aminobenzoic acids. In step 1, the anthranilic acids are smoothly converted to isatoic anhydrides using solid triphosgene in THF. In step 2, the anhydride electrophiles are reacted with the sodium enolate of ethyl acetoacetate, generated from sodium hydroxide, in warm N,N-dimethylacetamide resulting in the formation of substituted quinolines. A degradation–build-up strategy of the ethyl ester at the 3-position allowed for the construction of the α-hydroxyacetic acid residue required for the synthesis of key arylquinolines involved in an HIV integrase project.

15 October 2009 in The Journal of Organic Chemistry
Verified
Journal Article
Closed access
DYDexi Yang
Dexi Yang
VCValerie Cwynar
Valerie Cwynar
MDMatthew Donahue
Matthew Donahue
DHDavid J. Hart
David J. Hart
GMGrace Mbogo
Grace Mbogo

1 January 2021 in Journal of Biological Chemistry
Verified
Journal Article
Open access
JSJian Sun
Jian Sun
KPKrunal Hiteshkumar Patel
Krunal Hiteshkumar Patel
JHJared Hume
Jared Hume
Julie A. PigzaJulie A. Pigza
Julie A. Pigza
MDMatthew Donahue
Matthew Donahue
JKJACQUES KESSL
JACQUES KESSL
During the integration step, HIV-1 integrase (IN) interacts with viral DNA and the cellular cofactor LEDGF/p75 to effectively integrate the reverse transcript into the host chromatin. Allosteric HIV-1 integrase inhibitors (ALLINIs) are a new class of antiviral agents that bind at the dimer interface of the IN catalytic core domain and occupy the binding site of LEDGF/p75. While originally designed to block IN-LEDGF/p75 interactions during viral integration, several of these compounds have been shown to also severely impact viral maturation through an IN multimerization mechanism. In this study, we tested the hypothesis that these dual properties of ALLINIs could be decoupled toward late stage viral replication effects by generating additional contact points between the bound ALLINI and a third subunit of IN. By sequential derivatization at position 7 of a quinoline-based ALLINI scaffold, we show that IN multimerization properties are enhanced by optimizing hydrophobic interactions between the compound and the C-terminal domain of the third IN subunit. These features not only improve the overall anti-viral potencies of these compounds but also significantly shift the ALLINIs selectivity toward the viral maturation stage. Thus, we demonstrate that in order to fully maximize the potency of ALLINIs, the interactions between the inhibitor and all three IN subunits need to be simultaneously optimized.

1 November 2006 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
MDMatthew Donahue
Matthew Donahue
JJJeffrey N. Johnston
Jeffrey N. Johnston